GEV Stock Analysis: GE Vernova | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 267.593m USD | 12M Return: 54.1% | US36828A1016 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.05B
Qual. Beats: 0
Rev. Trend: 98.9%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 2.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
GE Vernova Inc. (NYSE: GEV) is a U.S.-based energy company that designs, manufactures, and services equipment and software across the electricity value chain-from generation through transmission, distribution, conversion, storage, and orchestration. Operating globally across the Americas, Europe, Asia, the Middle East, and Africa, the company is organized into three reporting segments: Power (gas, nuclear, hydro, and steam technologies), Wind (onshore and offshore wind turbines and blades), and Electrification (grid solutions, power conversion, electrification software, and solar and storage technologies).
The company is classified within the Industrials sector under the Heavy Electrical Equipment sub-industry, a category that includes manufacturers of power generation and transmission equipment serving utilities and industrial customers. GE Vernova was incorporated in 2023 in connection with its spin-off from General Electric and began trading as an independent public company on March 27, 2024. Headquartered in Cambridge, Massachusetts, the business spans both conventional power generation and renewable energy technologies, positioning it across multiple secular themes in the global energy transition.
- AI data center demand boosts electrification segment orders
- Wind segment margins pressured by offshore project cancellations
- Nuclear and gas turbine backlog expands on rising power demand
| Net Income: 9.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 10.29 > 1.0 |
| NWC/Revenue: -20.30% < 20% (prev 2.59%; Δ -22.89% < -1%) |
| CFO/TA 0.17 > 3% & CFO 14.1b > Net Income 9.53b |
| Net Debt (-8.32b) to EBITDA (9.08b): -0.92 < 3 |
| Current Ratio: 0.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (270.0m) vs 12m ago -2.17% < -2% |
| Gross Margin: 20.21% > 18% (prev 18.02%; Δ 2.19% > 0.5%) |
| Asset Turnover: 61.80% > 50% (prev 69.00%; Δ -7.20% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: -0.10 (Total Current Assets 47.4b - Total Current Liabilities 55.8b) / Total Assets 80.8b |
| B: 0.14 (Retained Earnings 11.3b / Total Assets 80.8b) |
| C: 0.12 (EBIT TTM 7.88b / Avg Total Assets 66.9b) |
| D: 0.18 (Book Value of Equity 12.0b / Total Liabilities 67.7b) |
| Altman-Z'' = 0.75 = B |
| DSRI: 1.11 (Receivables 20.6b/16.4b, Revenue 41.4b/36.6b) |
| GMI: 0.89 (GM 18.02% / 20.21%) |
| AQI: 1.32 (AQ_t 0.32 / AQ_t-1 0.24) |
| SGI: 1.13 (Revenue 41.4b / 36.6b) |
| TATA: -0.06 (NI 9.53b - CFO 14.1b) / TA 80.8b) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of October 13, 2026, the stock is trading at USD 996.80 with a total of 944,701 shares traded. Over the past week, the price has changed by +0.69%, over one month by +13.95%, over three months by -4.39% and over the past year by +54.12%.
Current recommended Stop Loss: 941.20 (which is 5.6% or 1.4 ATR below the current price).
GE Vernova has received a consensus analysts rating of 4.46. Therefore, it is recommended to buy GEV.
- StrongBuy: 24
- Buy: 6
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 1224.9 | 22.9% |
P/E Trailing = 28.8053
P/E Forward = 38.7597
P/S = 6.4688
P/B = 21.2011
P/EG = 1.8622
Revenue TTM = 41.4b USD
EBIT TTM = 7.88b USD
EBITDA TTM = 9.08b USD
Long Term Debt = 2.79b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 4.80b USD (from shortLongTermDebtTotal, last quarter) + Leases 844.0m
Net Debt = -8.32b USD (calculated: Debt 4.80b - CCE 13.1b)
Enterprise Value = 259b USD (268b + Debt 4.80b - CCE 13.1b)
Interest Coverage Ratio = unknown (Ebit TTM 7.88b / Interest Expense TTM 0.0)
EV/FCF = 20.84x (Enterprise Value 259b / FCF TTM 12.4b)
FCF Yield = 4.80% (FCF TTM 12.4b / Enterprise Value 259b)
FCF Margin = 30.07% (FCF TTM 12.4b / Revenue TTM 41.4b)
Net Margin = 23.03% (Net Income TTM 9.53b / Revenue TTM 41.4b)
Gross Margin = 20.21% ((Revenue TTM 41.4b - Cost of Revenue TTM 33.0b) / Revenue TTM)
Gross Margin QoQ = 21.26% (prev 19.08%)
Tobins Q-Ratio = 3.21 (Enterprise Value 259b / Total Assets 80.8b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 4.80b)
Taxrate = 29.84% (276.0m / 925.0m)
NOPAT = 5.53b (EBIT 7.88b * (1 - 29.84%))
Current Ratio = 0.85 (Total Current Assets 47.4b / Total Current Liabilities 55.8b)
Debt / Equity = 0.40 (Debt 4.80b / totalStockholderEquity, last quarter 12.0b)
Debt / EBITDA = -0.92 (Net Debt -8.32b / EBITDA 9.08b)
Debt / FCF = -0.67 (Net Debt -8.32b / FCF TTM 12.4b)
Total Stockholder Equity = 11.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.24% (Net Income 9.53b / Total Assets 80.8b)
RoE = 83.40% (Net Income TTM 9.53b / Total Stockholder Equity 11.4b)
RoCE = 55.41% (EBIT 7.88b / Capital Employed (Equity 11.4b + L.T.Debt 2.79b))
RoIC = 22.97% (NOPAT 5.53b / Invested Capital 24.1b)
WACC = 12.75% (E(268b)/V(272b) * Re(12.98%) + D(4.80b)/V(272b) * Rd(0.0%) * (1-Tc(0.30)))
Discount Rate = 12.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -42.13 | Cagr: -0.34%
[DCF] Terminal Value 65.09% ; FCFF base≈8.55b ; Y1≈9.80b ; Y5≈14.4b
[DCF] Fair Price = 487.6 (EV 122b - Net Debt -8.32b = Equity 130b / Shares 266.3m; r=12.75% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.20 | # QB: 0
Revenue Correlation: 98.87 | Revenue CAGR: 7.02% | SUE: 1.05 | # QB: 1
EPS current Quarter (2026-09-30): EPS=4.06 | Chg30d=-2.72% | Revisions=+0% | Analysts=14
EPS current Year (2026-12-31): EPS=30.49 | Chg30d=-0.81% | Revisions=+12% | GrowthEPS=+72.4% | GrowthRev=+21.7%
EPS next Year (2027-12-31): EPS=24.81 | Chg30d=+0.04% | Revisions=+29% | GrowthEPS=-18.6% | GrowthRev=+14.1%
[Analyst] Revisions Ratio: +19% (up=8, down=5)